Selinexor (Nexpovio®) (SVd) in Patients With Relapsed or Refractory Multiple Myeloma
Clinical trial NCT05954780 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05954780
- Sponsor
- iOMEDICO AG
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-06-28
- Primary completion
- 2026-10-30
- Enrollment
- 75
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.